Gene · 3597
Papers1,963
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,963
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chimeric Antigen Receptor T Cells in Glioblastoma-Current Concepts and Promising Future. | Cells | 2023 | 37443804 | PubTator, text mining | PubMed |
| LPS binding protein and activation signatures are upregulated during asthma exacerbations in children. | Respir Res | 2023 | 37438758 | PubTator, text mining | PubMed |
| Type 2 immunity in the brain and brain borders. | Cell Mol Immunol | 2023 | 37429945 | PubTator, text mining | PubMed |
| When the allergy alarm bells toll: The role of Toll-like receptors in allergic diseases and treatment. | Front Mol Biosci | 2023 | 37426425 | PubTator, text mining | PubMed |
| RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy. | Cell Biosci | 2023 | 37420298 | PubTator, text mining | PubMed |
| Novel Anti-Inflammatory Approaches to COPD. | Int J Chron Obstruct Pulmon Dis | 2023 | 37408603 | PubTator, text mining | PubMed |
| CAR-NK cell therapy for glioblastoma: what to do next? | Front Oncol | 2023 | 37404752 | PubTator, text mining | PubMed |
| Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8+ T cells against tumor. | J Immunother Cancer | 2023 | 37400134 | PubTator, text mining | PubMed |
| Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer. | Front Oncol | 2023 | 37377907 | PubTator, text mining | PubMed |
| Air Pollution and microRNAs: The Role of Association in Airway Inflammation. | Life (Basel) | 2023 | 37374157 | PubTator, text mining | PubMed |
| Intrinsic Effects of Exposome in Atopic Dermatitis: Genomics, Epigenomics and Regulatory Layers. | J Clin Med | 2023 | 37373692 | PubTator, text mining | PubMed |
| Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer. | Cell Rep Med | 2023 | 37348499 | PubTator, text mining | PubMed |
| Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. | Cancers (Basel) | 2023 | 37345109 | PubTator, text mining | PubMed |
| Quantifying Intratumoral Heterogeneity and Immunoarchitecture Generated In-Silico by a Spatial Quantitative Systems Pharmacology Model. | Cancers (Basel) | 2023 | 37345087 | PubTator, text mining | PubMed |
| The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness. | Neurologia (Engl Ed) | 2023 | 37344097 | PubTator, text mining | PubMed |
| Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study. | Dermatol Ther (Heidelb) | 2023 | 37318750 | PubTator, text mining | PubMed |
| Eblasakimab, a novel IL-13 receptor alpha 1 monoclonal antibody, blocks STAT6 phosphorylation with low dose in human volunteers. | Clin Immunol | 2023 | 37315681 | PubTator, text mining | PubMed |
| Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab. | Dermatol Ther (Heidelb) | 2023 | 37310643 | PubTator, text mining | PubMed |
| Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions. | Front Immunol | 2023 | 37304305 | PubTator, text mining | PubMed |
| Elastocaloric Waste/Natural Rubber Materials with Various Crosslink Densities. | Polymers (Basel) | 2023 | 37299363 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3597/papers?page=10